Australia-based Zelira Therapeutics Ltd. (OTCQB: ZLDAF), a company developing cannabinoid-based medicines, announced that it is entering the German market via a 5-year exclusive distribution agreement with IM Cannabis Corp. (CSE: IMCC) (NASDAQ:
Cannabidiol brand cbdMD, Inc. (NYSE: YCBD) announced partnerships with four CrossFit athletes to further expand their footprint in the global fitness landscape.
Multi-country medical and recreational cannabis operator IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC) reported its unaudited financial results on Monday for the three- and six-month periods ended June 30.